Paul E. Emery
Paul E. Emery publishes mostly in Rheumatology, Immunology and Hematology, on topics such as Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Systemic Lupus Erythematosus Research.
- World rank
- #24,326 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #1,778 of 367,258
- Works
- 1,623
- Citations
- 129k
- Citations per work
- 79.7
What does Paul E. Emery research?
Paul E. Emery's work is mostly in Medicine (64%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1,03463.7%
- Medicine1,03463.7%
- Everything else46128.4%
- Life Sciences1287.9%
- Immunology and Microbiology1287.9%
- 1Rheumatology45% of their works
- 2Immunology8% of their works
- 3Hematology6% of their works
- 4Pathology and Forensic Medicine6% of their works
- 5Radiology, Nuclear Medicine and Imaging4% of their works
- 6Genetics3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Autoimmune and Inflammatory Disorders Research
- Monoclonal and Polyclonal Antibodies Research
- Systemic Sclerosis and Related Diseases
- Chronic Lymphocytic Leukemia Research
- Biosimilars and Bioanalytical Methods
Which keywords describe Paul E. Emery's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Ankylosing Spondylitis, Spondyloarthritis, Antiphospholipid Syndrome, Systemic Lupus Erythematosus and Hemophagocytic Lymphohistiocytosis.
- Immunogenicity
- Genomic Aberrations
- Systemic Sclerosis
- Therapeutic Antibodies
- Monoclonal Antibodies
- Hemophagocytic Lymphohistiocytosis
- Antiphospholipid Syndrome
- Ankylosing Spondylitis
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Spondyloarthritis
- Systemic Lupus Erythematosus
- Juvenile Idiopathic Arthritis
- Fc Receptors
- Fibrosis
- Chronic Lymphocytic Leukemia
- Biosimilars
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Autoantibodies1,5273 topics
- Inflammation1,0431 topic
- Rheumatoid Arthritis1,0431 topic
- Ankylosing Spondylitis3991 topic
- Spondyloarthritis3991 topic
- Antiphospholipid Syndrome3621 topic
- Systemic Lupus Erythematosus3621 topic
- Hemophagocytic Lymphohistiocytosis2391 topic
- Juvenile Idiopathic Arthritis2391 topic
- Monoclonal Antibodies2362 topics
- Fc Receptors1461 topic
- Therapeutic Antibodies1461 topic
- Fibrosis1221 topic
- Systemic Sclerosis1221 topic
- Chronic Lymphocytic Leukemia1211 topic
- Genomic Aberrations1211 topic
- Biosimilars901 topic
- Immunogenicity901 topic
Where does Paul E. Emery work?
Paul E. Emery's main affiliation in the publication record is University of Leeds, United Kingdom.
How many publications and citations does Paul E. Emery have?
OpenAlex counts 1,623 works and 129,300 citations for Paul E. Emery, an h-index of 159, ranking #24,326 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Paul E. Emery. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.